Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease

• Verfasst von: Thome, Johannes [VerfasserIn]
• Verfasst von: Retz, Wolfgang [VerfasserIn]
• Verfasst von: Baader, Miriam [VerfasserIn]
• Verfasst von: Pesold, B. [VerfasserIn]
• Verfasst von: Hu, Mei [VerfasserIn]
• Verfasst von: Cowen, M. [VerfasserIn]
• Verfasst von: Durany, N. [VerfasserIn]
• Verfasst von: Adler, G. [VerfasserIn]
• Verfasst von: Henn, Fritz A. [VerfasserIn]
• Verfasst von: Rösler, Michael [VerfasserIn]
• Titel: Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease
• Verf.angabe: J. Thome, W. Retz, M. Baader, B. Pesold, M. Hu, M. Cowen, N. Durany, G. Adler, F.A. Henn, and M. Rösler
• E-Jahr: 2001
• Jahr: October 2001
• Umfang: 6 S.
• Fussnoten: Gesehen am 04.11.2020
• Titel Quelle: Enthalten in: Journal of neural transmission
• Ort Quelle: Wien [u.a.] : Springer, 1950
• Jahr Quelle: 2001
• Band/Heft Quelle: 108(2001), 10, Seite 1175-1180
• ISSN Quelle: 1435-1463
• DOI: doi:10.1007/s007020170007
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1737747197

Abstract

In order to identify gene variants related to the serotonergic neurotransmitter system that possibly represent a hereditary risk factor for sporadic Alzheimer's disease (AD), patients suffering from AD and non-demented psychiatric inpatients without symptoms of dementia were genotyped for polymorphisms of HTR6 (267C/T) and HTR2A (−1438G/A). Although there was a tendency toward an increased number of the genotype TT of the 5-HT6 receptor polymorphism in AD patients when compared to controls (2.8% vs. 1.3%), neither this nor the 5-HT2A promoter polymorphism showed significant differences in their genotypic or allelic distribution among patients and controls. These polymorphisms probably do not represent major genetic risk factors of AD. However, further studies including other genetic variants of the serotonergic neurotransmitter system are needed in order to elucidate their role in AD.